- Home
- Site Contents
- Our Founder
- Governance
- Faculty
- Strategic Plan
- Core Values
- Resources
- Programs - Research
- Programs - Education
- Programs - Service
- Clinical Trials
- Other Activities
- Press Releases 1980-1999
- Press Releases 2000-2009
- Press Releases 2010-2014
- Press Releases 2015-2019
- Press Releases 2020-2024
- Press Releases 2025-2029
- Blogs
- Podcasts
- LinkedIn Posts
- Conferences 2013-2017
- Conferences 2018
- Conferences 2019
- Conferences 2020
- Conferences 2021
- Conferences 2022
- Conferences 2023
- Patents
- Books & Monographs
- Book Contributions -1
- Book contributions -2
- Refereed Articles - 1
- Refereed Articles -2
- Refereed Articles - 3
- Refereed Articles - 4
- Abstracts 2013-2017
- Abstracts 2018-2019
- Abstracts 2020-2025
- Philanthropy
- Privacy Policy
ABSTRACTS (2020-2025)
2020
A. L. Fymat, Nanobiotechnology-Based Drugs for Treatment of Neurological Disorders, Invited Lecture Presentation at 6thEuropean Biopharma Congress, Amsterdam, The Netherlands., September 18-19, 2018. Journal of Pharmaceutical Bioprocessing 8(3):1-3, 2020.
A.L. Fymat, What Do We Know About Lewy Body Dementias, 2ndInternational Conference on Dementia and Dementia Care, Montreal, Canada, August 20-21, 2020.
A. L. Fymat, Exploring the Innovation and Excellence in the Field of Graphene Technologies and Carbon Nanotubes, Awards 2020, Open Access Journal of Engineering & Management 8:4, Milan Italy, 23-24 September 2020.
A. L. Fymat, Predicting and Preventing the next Pandemics,Keynote presented at the 7thAnnual International Conference of the Society for the Advancement of Science, Kampala, Uganda, October 26, 2020.
A. L. Fymat, Global Market Analysis on Nanomedicine and Drug Delivery Systems,presented at the 2nd European Congress on Nanomedicine and Drug Delivery Systems. Paris, France, 7-8 December 2020.
2021
A. L. Fymat, Nanobiotechnology for treatment of neurological disorders, 23rd International Conference on Pharmaceutical Biotechnology, 2021.
A. L. Fymat, Nanobiotechnology Roles in Brain Cancer Treatment, Invited Keynote Lecture, 6th European Biopharma Congress, New York, New York, USA, 5 April 2021.
A. L. Fymat, Roles of Nanotechnology in the Treatment of Glioblastomas and Neurological Diseases, Second International Conference and Exhibition on Pharmacology and Pharmaceutical Research, Dubai, UAE, April 23-24, 2021.
A. L. Fymat, Nanopharmacology in the Treatment of Neurodegenerative Disorders, International Pharmaceutical Research and Drug Development (GPD 2021) Conference, Prague, Czech Republic, May 14-15, 2021.
A. L. Fymat, Dementia : What do we know about the disease and what can be done about it? International Conference on Dementia, Singapore City, Singapore, June 21-22, 2021.
A. L. Fymat, On Alzheimer's Cure: 19 Important Questions Answered, Invited Keynote at the Fifth International Conference on Neurology & Therapeutics (Neurology 2021), Paris, France, July 7-8, 2021.
A. L. Fymat, Paradigm for pandemic prediction and prevention, presented at the European Union Academy of Sciences Pandemics (e2021 Symposium), Brussels, Belgium, July 15, 2021.
A. L. Fymat, Dementia: Is its root cause a runaway autoimmune disease? Geriatric & Gerontology Conference 2021, October 21-23, 2021, Prague, Czech Republic (converted to virtual).
A. L. Fymat, Glioblastoma surgical and non-surgical treatments: What progress made? Surgery 2021 International Conference & Exhibition on Surgery and Anesthesia, 2-4 December 2021, London, U.K.
2022
A. L. Fymat, On the surgical and non-surgical treatments of glioblastomas, International Conference on Surgery, 25-26 February 2022, Bangkok, Thailand.
A. L. Fymat, COVID-19 neurological manifestations, 2022 Neurology International Conference, Paris, France, April 25-26, 2022.
2023
A. L. Fymat, Dementia – Eliminating its possible reversible forms, 35th International Conference on Mental Health and Psychiatry, April 17-18, 2023, Paris, France.
A.L. Fymat, Multiple sclerosis: Role of autologous hematopoietic stem cells treatment, International Conference on Neuropsychiatry, Neurosurgery, and Rehabilitation Medicine, April 17-18, 2023, Rome, Italy.
2024
A. L. Fymat, Alzheimer's - A runaway autoimmune disease, Neuroforum 2024, Scholars World Congress on Neuroscience and Brain Disorders, Theme: "Emerging Perspectives in Neurology and Brain Research", 27-28 March 2024, Barcelona, Spain.
2025
2025